Cart summary

You have no items in your shopping cart.

GCN2iB

SKU: orb1309637

Description

GCN2iB

Research Area

Cell Biology

Images & Validation

Key Properties

CAS Number2183470-12-2
MW451.83
Purity99.08%
FormulaC18H12ClF2N5O3S
SMILESCOc1ncc(Cl)cc1S(=O)(=O)Nc1ccc(F)c(C#Cc2cnc(N)nc2)c1F
TargetPERK,Autophagy
Solubility10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.21 mM);H2O:< 0.1 mg/mL (insoluble);DMSO:56.5 mg/mL (125.05 mM)

Bioactivity

Target IC50
GCN2:2.4 nM
In Vivo
METHODS: HFD plus STZ-induced diabetic C57BL/6J mice were treated with intraperitoneal injection of GCN2iB (3 mg/kg) every other day for 6 weeks. At the end of the experiment, the mice were subjected to echocardiography. RESULTS After GCN2iB treatment, the fasting blood glucose level (11.18 ± 1.44 vs. 17.42 ± 2.57 mmol/L) and body weight (28.94 ± 2.05 vs. 32.54 ± 1.49 g) of type 2 diabetic mice were significantly reduced; GCN2iB treatment had no effect on heart weight. Significant effects, but increased heart weight to body weight ratio; GCN2iB treatment significantly improved cardiac systolic function and increased left ventricular (LV) ejection fraction (EF).
In Vitro
METHODS: HEK293 cells were treated with 4 nM to 4 μM Gcn2iB for 6 h in the presence or absence of Halofuginone (HF) treatment to explore the concentration-dependent effect of Gcn2iB on ISR activation. RESULTS HF treatment resulted in increased levels of p-Gcn2, p-eIF2α, and Atf4, each of which decreased with increasing concentrations of Gcn2iB; p-Gcn2 induction decreased at 62.5 nM Gcn2iB or higher, and Atf4 induction decreased at 250 nM Gcn2iB; cells treated with Gcn2iB in the absence of HF exhibited a biphasic response to the induction of p-Gcn2, p-eIF2α, and Atf4, with increases in all three ISR markers observed in the range of 10 to 100 nM Gcn2iB; above 250 nM Gcn2iB, p-Gcn2 levels decreased to below those determined with vehicle, and Atf4 levels were not significantly induced; although Gcn2iB could inhibit Gcn2 stimulation by HF treatment, lower concentrations of Gcn2iB activated Gcn2 and the ISR in the absence of external stress.

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Autophagy, Inhibitor, GCN2, GCN2iB, GCN-2iB, Eukaryotic Initiation Factor (eIF), inhibit

Similar Products

  • GCN2iB acetate [orb1739651]

    2183470-13-3

    511.8848

    C20H16ClF2N5O5S

    50 mg, 100 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

GCN2iB (orb1309637)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 120.00
5 mg
$ 220.00
1 ml x 10 mM (in DMSO)
$ 240.00
10 mg
$ 330.00
25 mg
$ 620.00
50 mg
$ 870.00
100 mg
$ 1,170.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry